Partner With Us

We are seeking strategic partnerships to accelerate development, expand clinical applications, and bring innovative technologies to market. We welcome opportunities for collaboration in co-development, licensing, distribution and investment partnerships.

Emerging Solutions

We are actively advancing next-generation orthopedic biomaterials designed to improve clinical performance and patient outcomes. Our current development efforts focus on enhancing osteoconductive and osteoinductive performance, accelerating healing and remodeling, improving injectability, and integrating antibiotic capabilities to support infection prevention and treatment.

Guided by our Surgeon Advisory Board — composed of key opinion leaders in orthopedic and sports medicine surgery — we align product design, clinical applications, and innovation priorities to ensure our development remains focused, impactful, and clinically grounded.

Our innovation pipeline targets critical needs across orthopedic care, including:

Subchondral bone augmentation

Hardware fixation and augmentation in osteoporotic bone

Osteonecrosis and avascular necrosis

Vertebral augmentation procedures

Infection prevention and treatment in bone repair and fusion

Building on our strengths in biomaterials and in-house tissue processing, we are pushing beyond conventional limits to transform advanced concepts into meaningful clinical solutions.

Connect with us to discover more about the new products we are bringing to life.

Our Capabilities

We combine our cross-functional team and deep expertise in biomaterials with vertically integrated development and manufacturing capabilities to advance orthopedic solutions from concept to commercialization.

Biomaterials Development: Experience in calcium phosphate cements and biologic-based systems designed to support bone regeneration and healing.

Cleanroom Manufacturing: Controlled environments enabling consistent, high-quality production of sensitive materials.

Tissue Processing: In-house capabilities aligned with Good Tissue Practices (GTP) for safe and effective handling of biologic materials.

Packaging & Labeling: Fully integrated, in-house processes supporting product integrity, traceability, and regulatory compliance.

OEM & Contract Manufacturing: Flexible partnership models supporting private label, co-development, and technology transfer.

Quality Management System Support: Established systems compliant with ISO 13485 and FDA requirements to support development, manufacturing, and regulatory readiness.

Integrated Testing: In-house evaluation through each stage —from raw materials to finished product — supports reliability and compliance.

Process Development & Scale-Up: Ability to translate early-stage concepts into manufacturable, scalable solutions.

End-to-End Product Development

From concept to commercialization, we provide end-to-end product development support tailored to your needs. Our integrated approach ensures seamless progression through design, development, validation, and launch—reducing risk and accelerating timelines.

Whether you need full lifecycle support or targeted expertise, Vivorté is your trusted partner in delivering high-quality, compliant, and innovative medical solutions.

Strong Alliances

Our collaborations with the University of Louisville Speed School of Engineering and Medical School provide access to cutting-edge research and clinical expertise, supporting the development of advanced orthopedic biomaterials and therapies.

Current Investors

Vivorté is supported by a number of distinguished investment partners. To become an investment partner, please contact us at info@vivorte.com

Kentucky Science Technology Corp
Commonwealth Seed Capital
Anchorage Angels
Yearling Fund II

Start a Conversation

We welcome inquiries from potential partners, investors, and collaborators interested in advancing orthopedic innovation. Whether you’re exploring co-development, OEM opportunities, or strategic partnerships, our team is ready to connect.